/
/
/

Neuland Laboratories Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018
₹642 Cr₹776 Cr₹440 Cr₹514 Cr₹293 Cr₹328 Cr₹398 Cr₹311 Cr₹440 Cr₹385 Cr₹393 Cr₹418 Cr₹363 Cr₹407 Cr₹269 Cr₹294 Cr₹221 Cr₹256 Cr₹236 Cr₹258 Cr₹201 Cr₹245 Cr₹245 Cr₹241 Cr₹205 Cr₹192 Cr₹204 Cr₹186 Cr₹181 Cr₹173 Cr₹171 Cr₹169 Cr₹154 Cr
₹8 Cr₹12 Cr₹8 Cr₹2 Cr₹8 Cr₹7 Cr₹4 Cr₹4 Cr₹5 Cr₹5 Cr₹2 Cr₹3 Cr₹2 Cr₹8 Cr₹93 L₹24 L₹51 L₹63 L₹2 Cr₹29 L₹2 Cr₹15 Cr₹20 L₹61 L₹70 L₹2 Cr₹1 Cr₹57 L₹52 L₹1 Cr₹41 L₹64 L₹1 Cr
₹650 Cr₹789 Cr₹448 Cr₹516 Cr₹301 Cr₹336 Cr₹402 Cr₹315 Cr₹444 Cr₹390 Cr₹395 Cr₹421 Cr₹365 Cr₹415 Cr₹270 Cr₹294 Cr₹222 Cr₹257 Cr₹238 Cr₹258 Cr₹203 Cr₹259 Cr₹246 Cr₹242 Cr₹206 Cr₹193 Cr₹205 Cr₹187 Cr₹182 Cr₹174 Cr₹172 Cr₹169 Cr₹155 Cr
₹445 Cr₹494 Cr₹386 Cr₹381 Cr₹278 Cr₹294 Cr₹328 Cr₹265 Cr₹333 Cr₹295 Cr₹287 Cr₹295 Cr₹280 Cr₹301 Cr₹229 Cr₹238 Cr₹205 Cr₹229 Cr₹217 Cr₹227 Cr₹187 Cr₹230 Cr₹209 Cr₹210 Cr₹180 Cr₹169 Cr₹184 Cr₹170 Cr₹170 Cr₹161 Cr₹163 Cr₹160 Cr₹150 Cr
₹231 Cr₹320 Cr₹85 Cr₹157 Cr₹42 Cr₹59 Cr₹91 Cr₹67 Cr₹128 Cr₹112 Cr₹123 Cr₹141 Cr₹99 Cr₹128 Cr₹55 Cr₹70 Cr₹29 Cr₹40 Cr₹34 Cr₹43 Cr₹28 Cr₹40 Cr₹47 Cr₹41 Cr₹35 Cr₹32 Cr₹29 Cr₹26 Cr₹19 Cr₹20 Cr₹16 Cr₹15 Cr₹10 Cr
₹7 Cr₹7 Cr₹7 Cr₹5 Cr₹5 Cr₹2 Cr₹2 Cr₹1 Cr₹3 Cr₹4 Cr₹4 Cr₹4 Cr₹2 Cr₹4 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹4 Cr₹4 Cr₹5 Cr₹4 Cr₹4 Cr₹5 Cr₹7 Cr₹6 Cr₹5 Cr₹4 Cr₹5 Cr₹3 Cr₹4 Cr₹4 Cr
₹198 Cr₹287 Cr₹54 Cr₹129 Cr₹18 Cr₹39 Cr₹128 Cr₹49 Cr₹130 Cr₹92 Cr₹104 Cr₹122 Cr₹83 Cr₹110 Cr₹39 Cr₹53 Cr₹13 Cr₹24 Cr₹18 Cr₹28 Cr₹12 Cr₹24 Cr₹32 Cr₹29 Cr₹20 Cr₹17 Cr₹16 Cr₹12 Cr₹8 Cr₹8 Cr₹6 Cr₹5 Cr₹71 L
₹148 Cr₹213 Cr₹41 Cr₹97 Cr₹14 Cr₹28 Cr₹102 Cr₹33 Cr₹98 Cr₹68 Cr₹81 Cr₹89 Cr₹62 Cr₹85 Cr₹31 Cr₹38 Cr₹10 Cr₹22 Cr₹13 Cr₹20 Cr₹9 Cr₹17 Cr₹27 Cr₹21 Cr₹15 Cr-₹9 Cr₹11 Cr₹9 Cr₹6 Cr₹7 Cr₹5 Cr₹5 Cr₹57 L

Share Price Live Stats

Open (₹)23,095.00
Volume (₹)9,336.00
High (₹)23,095.00
Upper Circuit27,465.00
Low (₹)22,690.00
Lower Circuit18,315.00
Prev Close22,890.00
52W High (₹)23,881.00
Price22,830.00
52W Low (₹)11,500.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)29406.90 Cr
Div. Yield (%)0.15
PE Ratio59.08
Debt to Equity0.10
Price to Book8.23
Book Value1,460.31
EPS (TTM)387.98
Face Value10.00
ROE (%)21.43

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
NEULANDLABNSE
LTP
1W Low
1W High
Market cap (₹)
1903.4-16.6 (-0.86%)
1900.10
1984.80
4,56,833Cr
9159-80 (-0.87%)
9087
9467
2,45,426Cr
4846-204 (-4.04%)
4844.50
5066
1,87,320Cr
1132.2-58.8 (-4.94%)
1125.10
1187
1,13,217Cr
1378.3-45.2 (-3.18%)
1376.70
1426.10
1,12,212Cr
1845.3-93.2 (-4.81%)
1811.70
1949
1,01,155Cr
2112.2-59.3 (-2.73%)
2111.10
2192
97,626Cr
2337-45.9 (-1.93%)
2335
2419.20
96,859Cr
1161.6-16.4 (-1.39%)
1154.40
1179.90
96,406Cr
1656.5+11.2 (0.68%)
1622.60
1717
93,614Cr
22830-375 (-1.62%)
22690
23332
29,407Cr

Key Highlights of Neuland Laboratories Ltd’s P&L

In 2026-03-31, Neuland Laboratories Ltd reported total revenue of ₹2053.16Cr, compared with ₹1497.35Cr in 2025-03-31, reflecting Neuland Laboratories Ltd turnover.

Depreciation was ₹91.74Cr and finance costs were ₹23.95Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹488.98Cr in 2026-03-31 as compared to ₹346.33Cr in 2025-03-31.

Net Profit (PAT) was ₹364Cr in 2026-03-31 compared with ₹260.11Cr in 2025-03-31.

Earnings per share (EPS) were ₹283.71 in 2026-03-31, compared with ₹202.74 in 2025-03-31.